dc.contributor.author | Drake, Adam | |
dc.contributor.author | Chen, Jianzhu | |
dc.contributor.author | Chen, Qingfeng | |
dc.date.accessioned | 2013-01-08T14:47:19Z | |
dc.date.available | 2013-01-08T14:47:19Z | |
dc.date.issued | 2012-05 | |
dc.identifier.issn | 1672-7681 | |
dc.identifier.issn | 2042-0226 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/76183 | |
dc.description.abstract | Humanized mice are immunodeficient animals engrafted with human hematopoietic stem cells that give rise to various lineages of human blood cells throughout the life of the mouse. This article reviews recent advances in the generation of humanized mice, focusing on practical considerations. We discuss features of different immunodeficient recipient mouse strains, sources of human hematopoietic stem cells, advances in expansion and genetic modification of hematopoietic stem cells, and techniques to modulate the cytokine environment of recipient mice, in order to enhance reconstitution of specific human blood lineage cells. We highlight the opportunities created by new technologies and discuss practical considerations on how to make best use of the widening array of basic models for specific research applications. | en_US |
dc.description.sponsorship | Massachusetts Institute of Technology. Singapore-MIT Alliance in Research and Technology (SMART) | en_US |
dc.description.sponsorship | Ragon Institute of MGH, MIT and Harvard | en_US |
dc.language.iso | en_US | |
dc.publisher | Nature Publishing Group | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1038/cmi.2012.6 | en_US |
dc.rights | Creative Commons Attribution-Noncommercial-Share Alike 3.0 | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | en_US |
dc.source | Chen via Courtney Crummett | en_US |
dc.title | Engineering humanized mice for improved hematopoietic reconstitution | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Drake, Adam C, Qingfeng Chen, and Jianzhu Chen. “Engineering Humanized Mice for Improved Hematopoietic Reconstitution.” Cellular and Molecular Immunology 9.3 (2012): 215–224. | en_US |
dc.contributor.department | Singapore-MIT Alliance in Research and Technology (SMART) | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.contributor.approver | Chen, Jianzhu | |
dc.contributor.mitauthor | Drake, Adam | |
dc.contributor.mitauthor | Chen, Jianzhu | |
dc.contributor.mitauthor | Chen, Qingfeng | |
dc.relation.journal | Cellular and Molecular Immunology | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Drake, Adam C; Chen, Qingfeng; Chen, Jianzhu | en |
dc.identifier.orcid | https://orcid.org/0000-0002-5687-6154 | |
mit.license | OPEN_ACCESS_POLICY | en_US |
mit.metadata.status | Complete | |